Bavarian Nordic (OTCMKTS:BVNRY) Shares Gap Down – What’s Next?

Bavarian Nordic (OTCMKTS:BVNRY) gapped down before the market opened on Tuesday . The stock had previously closed at $11.44, but opened at $10.88. Bavarian Nordic shares last traded at $10.88, with a volume of 556 shares changing hands.

Bavarian Nordic Stock Performance

The stock’s 50 day moving average is $9.77 and its 200 day moving average is $9.77. The company has a market capitalization of $2.59 billion, a PE ratio of 10.99 and a beta of 1.20.

Bavarian Nordic (OTCMKTS:BVNRY) last issued its earnings results on Friday, August 21st. The company reported $0.46 EPS for the quarter. The business had revenue of $316.47 million during the quarter. Bavarian Nordic had a return on equity of 12.06% and a net margin of 24.36%.

About Bavarian Nordic

Bavarian Nordic is a fully integrated biotechnology company specializing in the development, manufacture and commercialization of vaccines and immunotherapies. Founded in 1994 and headquartered in Martinsried, Germany, the company combines internal research capabilities with in-house manufacturing to address serious infectious diseases and cancer indications. Bavarian Nordic’s operations encompass preclinical research, clinical development and commercial supply, with a strategic focus on leveraging its proprietary viral vector platforms.

The company’s commercial portfolio includes approved prophylactic vaccines such as Jynneos™ (marketed as Imvamune®/Imvanex®) for the prevention of smallpox and monkeypox in the United States, European Union and Canada; Rabipur® for rabies prevention; and Encepur® against tick-borne encephalitis.